Prebiotic nut compounds and human microbiota
- PMID: 27224877
- PMCID: PMC5646185
- DOI: 10.1080/10408398.2015.1096763
Prebiotic nut compounds and human microbiota
Abstract
Nut consumption is clearly related to human health outcomes. Its beneficial effects have been mainly attributed to nut fatty acid profiles and content of vegetable protein, fiber, vitamins, minerals, phytosterols and phenolics. However, in this review we focus on the prebiotics properties in humans of the non-bioaccessible material of nuts (polymerized polyphenols and polysaccharides), which provides substrates for the human gut microbiota and on the formation of new bioactive metabolites and the absorption of that may partly explain the health benefits of nut consumption.
Keywords: Nuts; butyrate; fiber; polyphenols; polysaccharides; urolithins; valerolactones.
Figures
References
-
- Abe L. T., Lajolo F. M. and Genovese M. I. (2010). Comparison of phenol content and antioxidant capacity of nuts. Ciência e Tecnol. Aliment. :254–259.
-
- American Institute for Cancer Research (2015). No Title [Internet] Available from: <fight-cancer/tab-content/walnuts-research.html>.
-
- Appeldoorn M. M., Vincken J.-P., Aura A.-M., Hollman P. C. H. and Gruppen H. (2009). Procyanidin dimers are metabolized by human microbiota with 2-(3,4-dihydroxyphenyl)acetic acid and 5-(3,4-dihydroxyphenyl)-gamma-valerolactone as the major metabolites. J. Agric. Food Chem. :1084–1092. - PubMed
-
- Babio N., Toledo E., Estruch R., Ros E., Martínez-González M. A., Castañer O., Bulló M., Corella D., Arós F., Gómez-Gracia E., Ruiz-Gutiérrez V., Fiol M., Lapetra J., Lamuela-Raventos R. M., Serra-Majem L., Pintó X., Basora J., Sorlí J. V. and Salas-Salvadó J. (2014). Mediterranean diets and metabolic syndrome status in the PREDIMED randomized trial. CMAJ. :E649–E657. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources